 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$2.59 |
$2.65 |
$2.53 |
$2.61 |
41.90K | | 04/16/2024 |
$2.50 |
$2.65 |
$2.48 |
$2.49 |
84.30K | | 04/17/2024 |
$2.57 |
$2.61 |
$2.45 |
$2.46 |
6.90K | | 04/18/2024 |
$2.53 |
$2.63 |
$2.30 |
$2.47 |
15.00K | | 04/19/2024 |
$2.58 |
$2.58 |
$2.51 |
$2.55 |
11.70K |
|
|
| Cellectis is a clinical stage biotechnological company. Co. is developing a series of product candidates for hematologic cancers. Co.'s primary immuno-oncology product candidates, which it refers to as Universal Chimeric Antigen Receptor T-cells, are allogeneic CAR T-cells engineered to be used as an off-the-shelf treatment. UCART is a therapeutic product line that it is developing with its gene-editing platform to address unmet medical needs in oncology. Co. is focusing its initial internal pipeline in the hematologic cancer space, targeting diseases such as Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma and other types of cancers. | |
|
Cellectis SA (CLLS) has the following price history information. Looking back at CLLS historical stock prices for the last five trading days, on April 15, 2024, CLLS opened at $2.59, traded as high as $2.65 and as low as $2.53, and closed at $2.61. Trading volume was a total of 41.90K shares. On April 16, 2024, CLLS opened at $2.50, traded as high as $2.65 and as low as $2.48, and closed at $2.49. Trading volume was a total of 84.30K shares. On April 17, 2024, CLLS opened at $2.57, traded as high as $2.61 and as low as $2.45, and closed at $2.46. Trading volume was a total of 6.90K shares. On April 18, 2024, CLLS opened at $2.53, traded as high as $2.63 and as low as $2.30, and closed at $2.47. Trading volume was a total of 15.00K shares. On April 19, 2024, CLLS opened at $2.58, traded as high as $2.58 and as low as $2.51, and closed at $2.55. Trading volume was a total of 11.70K shares.
CLLS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cellectis SA shares, starting with a $10,000 purchase of CLLS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/25/2015 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$39.30 |
|
| End price/share: |
$2.55 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-93.51% |
|
| Average Annual Total Return: |
-26.02% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$648.62 |
|
| Years: |
9.08 |
|
|
|
| Date |
Close |
| 04/15/2024 | $2.61 | | 04/16/2024 | $2.49 | | 04/17/2024 | $2.46 | | 04/18/2024 | $2.47 | | 04/19/2024 | $2.55 |
|
|
